• Self-study / Enduring
S2-A 2025: Use of Urine in the Care of Patients with Monoclonal Proteins
  • Immunology
All laboratory personnel from a laboratory that participated in the S2-A 2025 Immunology, Special Surveys program.
  • 1.00 CE
  • 1.00 Physician Participation
  • Self-study / Enduring
S-A 2025: Use of Urine in the Care of Patients with Monoclonal Proteins
  • Immunology
All laboratory personnel from a laboratory that participated in the S-A 2025 Immunology Surveys program.
  • 1.00 CE
  • 1.00 Physician Participation
  • Self-study / Enduring
RDS-A 2025: Use of Urine in the Care of Patients with Monoclonal Proteins
  • Immunology
All laboratory personnel from a laboratory that participated in the RDS-A 2025 Rheumatic Disease Special Serologies Surveys program.
  • 1.00 CE
  • 1.00 Physician Participation
  • Self-study / Enduring
M-A 2025: Use of Urine in the Care of Patients with Monoclonal Proteins
  • Immunology
All laboratory personnel from a laboratory that participated in the M-A 2025 Cerebrospinal Fluid Chemistry and Oligoclonal Bands Surveys program.
  • 1.00 CE
  • 1.00 Physician Participation
  • Self-study / Enduring
G-A 2025: Use of Urine in the Care of Patients with Monoclonal Proteins
  • Immunology
All laboratory personnel from a laboratory that participated in the G-A 2025 Syphilis Serology Surveys program.
  • 1.00 CE
  • 1.00 Physician Participation
  • Self-study / Enduring
SPE-A 2025: Use of Urine in the Care of Patients with Monoclonal Proteins
  • Immunology
All laboratory personnel from a laboratory that participated in the SPE-A 2025 Protein Eletrophoresis Surveys program.
  • 1.00 CE
  • 1.00 Physician Participation
  • Self-study / Enduring
HE-B 2025: Burkitt Lymphoma
  • Hematology/ Hematopathology
All laboratory personnel from a laboratory that participated in the HE-B 2025 Hematology, Basic Surveys program.
  • 1.00 CE
  • 1.00 Physician Participation
  • Self-study / Enduring
BCP-B 2025: Burkitt Lymphoma
  • Hematology/ Hematopathology
All laboratory personnel from a laboratory that participated in the BCP-B 2025 Blood Cell Identification, Photographs Surveys program.
  • 1.00 CE
  • 1.00 Physician Participation
  • Self-study / Enduring
BCPV-B 2025: Burkitt Lymphoma
  • Hematology/ Hematopathology
All laboratory personnel from a laboratory that participated in the BCPV-B 2025 Blood Cell Identification, Virtual Surveys program.
  • 1.00 CE
  • 1.00 Physician Participation
  • Self-study / Enduring
FH (1-4, 9, 10, 13, 16, 17)-B 2025: Burkitt Lymphoma
  • Hematology/ Hematopathology
All laboratory personnel from a laboratory that participated in the FH (1-4, 9, 10, 13, 16, 17)-B 2025, Hematology Automated Differential Series Surveys program.
  • 1.00 CE
  • 1.00 Physician Participation

Pages